La Lingua Nostra La Lingua Nostra
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Blogs
  • Offres
  • Emplois
  • Articles
  • Posts
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • ROHIT GAURYA Ajout d’un nouvel article Health
    2026-04-08 09:52:39 -
    Ad5-nCoV Vaccine Market Growth & CAGR 12.5% Forecast
    According to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032. Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...
    0 Commentaires 0 Parts 30 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • ROHIT GAURYA Ajout d’un nouvel article Health
    2026-03-18 09:46:28 -
    Meningococcal Polysaccharide Vaccine Market to Reach USD 4.5 Billion by 2030 | CAGR 6.3%
        According to a newly published market research report by 24LifeSciences, global meningococcal polysaccharide vaccine market was valued at USD 2.8 billion in 2023 and is projected to reach USD 4.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2024-2030. Meningococcal polysaccharide vaccines are immunogenic preparations...
    0 Commentaires 0 Parts 235 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Rohit Katkam Ajout d’un nouvel article Autre
    2026-04-01 10:05:46 -
    Nucleic Vaccine Market Growth Report 2034: Rising at 2.8% CAGR with Expanding Therapeutic Applications
    According to a new report from Intel Market Research, the global Nucleic Vaccine market was valued at USD 49.34 billion in 2024 and is projected to reach USD 59.64 billion by 2034, growing at a CAGR of 2.8% during the forecast period. This growth reflects the transformative impact of mRNA vaccine technology, particularly evident in the rapid response to the COVID-19 pandemic, alongside...
    0 Commentaires 0 Parts 147 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
© 2026 La Lingua Nostra French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Environ Conditions générale de vente Confidentialité Contactez nous